Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand
CONCLUSIONS: Boosters provide high level of protection against severe COVID-19 outcomes and deaths with newer omicron sub-lineages. Booster campaigns should focus on improving coverage utilising all available vaccines to ensure optimal protection.PMID:37880062 | DOI:10.1016/j.jmii.2023.10.001
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Kannikar Intawong Suwat Chariyalertsak Kittipan Chalom Thanachol Wonghirundecha Woravut Kowatcharakul Aksara Thongprachum Narain Chotirosniramit Kajohnsak Noppakun Krit Khwanngern Worachet Teacharak Prapon Piamanant Pimpinan Khammawan Sopon Iamsirithaworn Source Type: research
More News: Allergy & Immunology | Covid Vaccine | COVID-19 | Laboratory Medicine | Microbiology | Pandemics | Study | Thailand Health | Vaccines